483
Madeleine Duvic, M.D.Madeleine Duvic, M.D. – FDA 483, Jan 13, 2023
Record Details
An FDA inspection of Madeleine Duvic, M.D., a clinical investigator in Houston, revealed significant deficiencies in the conduct of Study E7777-G000-302. Observations included a failure to timely report a serious adverse event to the sponsor, obtaining informed consent from a non-English speaking subject using an English document, and inadequate maintenance of dosing records. These issues indicate a lack of adherence to investigational plan requirements and informed consent regulations.
- Person
View Company Profile
ID · 9a9d50ce-a017-4d6e-b868-c2e5b05a4d64
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.